Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000029

Chief Medical Officer sold 55,771 shares at an average $15.76 ($879,008)

  • Chief Medical Officer acquired 1,606 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-04-01 Option exercise 10b5-1 +1,606 $1.08 $1,734 172,475 D
Rodman David Malcom Chief Medical Officer 2025-04-01 Sale 10b5-1 −30,574 $15.00 $458,543 141,901 D
Rodman David Malcom Chief Medical Officer 2025-04-01 Sale 10b5-1 −2,791 $16.02 $44,717 139,110 D
Rodman David Malcom Chief Medical Officer 2025-04-01 Sale 10b5-1 −22,406 $16.77 $375,749 116,704 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-04-01 Option exercise · Stock Option 10b5-1 −1,606 114,274 D
Open-market sales · 55,771 sh · avg $15.76 · $879,008
Loading xslF345X05/wk-form4_1743716211.xml…